barriers to getting a glp-1 medication prescribed abandonment rates remain high despite booming demand GLP-1s: Brace yourself for the
Description
H.R.4818 - Treat and Reduce Obesity Act of 2023

Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me...

The weight loss difference for non-diabetic individuals taking GLP-1 RAs compared to a placebo is more pronounced, ranging from 6.1-17.4%
Ann N Y Acad Sci 1212:97113 Berthoud H-R (2002) Multiple neural systems controlling food intake and body weight

It will be pretty comprehensive, so dont feel shy about skimming